Calithera Biosciences, Inc. (CALA) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by and welcome to CaliFair Biosciences 1Q22 Earnings. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. If anyone should require assistance during the conference, please press star zero on your touchtone telephone. I would like to turn the conference over to your host, Ms. Stephanie Wong. Please go ahead. Thank you, Grace. Good afternoon, everyone. Welcome to our first quarter 2022 conference call. Joining me today are Susan Molyneux, founder, president, and CEO, and Emil Curiakos, chief medical officer. Earlier this afternoon, we issued a press release which included an overview of our first quarter 2022 financial and operational results, which can be accessed through our website at calathera.com. Before we begin, I would like to remind you that today's discussion will include statements about our future expectations, plans, and prospects. that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results made differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of our periodic filings with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our views change. Please note that this call is being recorded. And with that, I'll turn the call over to S...